Journal of Rheumatic Diseases

Cited by CrossRef (8)

  1. So Hye Nam, Doo-Ho Lim, Hyun Mi Heo, Ji Seon Oh, Hyouk-Soo Kwon, Tae-Bum Kim, Soo Min Ahn, Seokchan Hong, Chang-Keun Lee, Bin Yoo, Yong-Gil Kim. Anaphylaxis to Tocilizumab in Patients with Rheumatic Disease. Immunotherapy 2021;13:1483
    https://doi.org/10.2217/imt-2020-0307
  2. Željka Kardum, Ana Šimac, Kristina Frketić Marović, Ana Marija Masle, Jasminka MIlas Ahić. SEVERE HYPOFIBRINOGENEMIA IN A PATIENT WITH GIANT CELL ARTERITIS TREATED WITH TOCILIZUMAB: CASE-BASED REVIEW. AAEE 2023;2:210
    https://doi.org/10.56543/aaeeu.2023.2.4.05
  3. Soo Min Ahn, Ji Seon Oh, Hyun Mi Heo, Seokchan Hong, Chang-Keun Lee, Bin Yoo, Yong-Gil Kim. Predictive Factors for Rheumatoid Arthritis Flare After Switching From Intravenous to Subcutaneous Formulation of Tocilizumab in Real-World Practice. J Korean Med Sci 2022;37
    https://doi.org/10.3346/jkms.2022.37.e138
  4. Anaís Mariscal, Carlos Zamora, César Díaz-Torné, Mᵃ Àngels Ortiz, Juan José de Agustín, Delia Reina, Paula Estrada, Patricia Moya, Héctor Corominas, Sílvia Vidal. Increase of Circulating Monocyte–Platelet Conjugates in Rheumatoid Arthritis Responders to IL-6 Blockage. IJMS 2022;23:5748
    https://doi.org/10.3390/ijms23105748
  5. Hong Ki Min, Se Hee Kim, Hae-Rim Kim, Sang-Heon Lee. Therapeutic Utility and Adverse Effects of Biologic Disease-Modifying Anti-Rheumatic Drugs in Inflammatory Arthritis. IJMS 2022;23:13913
    https://doi.org/10.3390/ijms232213913
  6. . Tocilizumab. Reactions Weekly 2023;1969:344
    https://doi.org/10.1007/s40278-023-44810-6
  7. Ayman M. Al-Qaaneh, Fuad H. Al-Ghamdi, Sayed AbdulAzeez, J. Francis Borgio. Safety of Tocilizumab in COVID-19 Patients and Benefit of Single-Dose: The Largest Retrospective Observational Study. Pharmaceutics 2022;14:624
    https://doi.org/10.3390/pharmaceutics14030624
  8. Mohamed H. Bikhet, Christophe Hansen‐Estruch, Mariyam Javed, Dalis E. Collins, Jeremy B. Foote, David Ayares, Hidetaka Hara, David K. C. Cooper. Profound thrombocytopenia associated with administration of multiple anti‐inflammatory agents in baboons. Immunity Inflam & Disease 2022;10
    https://doi.org/10.1002/iid3.588